• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼的药物依从性:优化患者依从性的方法

Medication adherence in glaucoma: approaches for optimizing patient compliance.

作者信息

Tsai James C

机构信息

Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

Curr Opin Ophthalmol. 2006 Apr;17(2):190-5. doi: 10.1097/01.icu.0000193078.47616.aa.

DOI:10.1097/01.icu.0000193078.47616.aa
PMID:16552255
Abstract

PURPOSE OF REVIEW

To summarize recent literature regarding medication adherence with a focus on the complexities inherent in glaucoma management.

RECENT FINDINGS

Adherence to medications can be enhanced by undertaking the following strategies: enhanced patient education; improved dosing schedules; increased accessibility to healthcare (including longer hours, evening hours, and shorter wait times), and improved provider-patient relationships (e.g. increased trust). Patients may be less likely to forgo medication use due to cost pressures if the physician trust level is high. Recent studies suggest a role for baseline screening for adherence predictors and focused interventions in addressing modifiable risk factors for poor adherence (such as depression, stress, and lower education).

SUMMARY

Many factors are associated with the lack of medication adherence in patients. The solution is likely to be multi-dimensional and employ combination strategy (must be individualized for the patient). Educational interventions involving patients, family members, or both can be effective in improving adherence.

摘要

综述目的

总结近期关于药物依从性的文献,重点关注青光眼管理中固有的复杂性。

近期发现

可通过以下策略提高药物依从性:加强患者教育;改进给药方案;增加医疗服务的可及性(包括延长工作时间、提供夜间服务以及缩短等待时间),以及改善医患关系(如增强信任)。如果医生的信任度较高,患者因成本压力而放弃用药的可能性可能会降低。近期研究表明,对依从性预测因素进行基线筛查以及针对可改变的依从性差风险因素(如抑郁、压力和低教育水平)进行有针对性的干预具有重要作用。

总结

患者缺乏药物依从性与许多因素有关。解决方案可能是多维度的,并采用联合策略(必须针对患者个体化)。涉及患者、家庭成员或两者的教育干预措施在提高依从性方面可能有效。

相似文献

1
Medication adherence in glaucoma: approaches for optimizing patient compliance.青光眼的药物依从性:优化患者依从性的方法
Curr Opin Ophthalmol. 2006 Apr;17(2):190-5. doi: 10.1097/01.icu.0000193078.47616.aa.
2
A comprehensive perspective on patient adherence to topical glaucoma therapy.关于患者对局部青光眼治疗依从性的全面观点。
Ophthalmology. 2009 Nov;116(11 Suppl):S30-6. doi: 10.1016/j.ophtha.2009.06.024.
3
Overcoming barriers: the role of providers in improving patient adherence to antihypertensive medications.克服障碍:医疗服务提供者在提高患者抗高血压药物依从性方面的作用
Curr Opin Cardiol. 2006 Jul;21(4):310-5. doi: 10.1097/01.hco.0000231400.10104.e2.
4
A clinician's guide to the assessment and management of nonadherence in glaucoma.青光眼治疗依从性评估与管理的临床医生指南
Ophthalmology. 2009 Nov;116(11 Suppl):S43-7. doi: 10.1016/j.ophtha.2009.06.022.
5
Patient-centered communication to assess and enhance patient adherence to glaucoma medication.以患者为中心的沟通,用以评估和提高患者对青光眼药物治疗的依从性。
Ophthalmology. 2009 Nov;116(11 Suppl):S37-42. doi: 10.1016/j.ophtha.2009.06.023.
6
Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.青光眼依从性和持续性研究中的医患沟通、健康相关信念与青光眼治疗依从性
Ophthalmology. 2008 Aug;115(8):1320-7, 1327.e1-3. doi: 10.1016/j.ophtha.2007.11.023. Epub 2008 Mar 5.
7
The role of patient-physician trust in moderating medication nonadherence due to cost pressures.患者与医生之间的信任在缓解因费用压力导致的用药不依从方面的作用。
Arch Intern Med. 2005;165(15):1749-55. doi: 10.1001/archinte.165.15.1749.
8
Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS).利用药房报销数据研究青光眼药物治疗的依从性:青光眼依从性和持续性研究(GAPS)的方法与结果
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5052-7. doi: 10.1167/iovs.07-0290.
9
Risk factors for poor adherence to eyedrops in electronically monitored patients with glaucoma.电子监测的青光眼患者滴眼剂依从性差的危险因素。
Ophthalmology. 2009 Jun;116(6):1097-105. doi: 10.1016/j.ophtha.2009.01.021. Epub 2009 Apr 19.
10
Health literacy and adherence to glaucoma therapy.健康素养与青光眼治疗依从性
Am J Ophthalmol. 2006 Aug;142(2):223-6. doi: 10.1016/j.ajo.2006.03.018.

引用本文的文献

1
Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies.青光眼药物治疗的药物利用、依从性及药物变更和停药的预测因素
Adv Ther. 2025 Jun 6. doi: 10.1007/s12325-025-03247-y.
2
Adopting Interventional Glaucoma Via Sustained-Release Therapies: The Wide-Ranging Impact of Procedural Pharmaceuticals in Ophthalmology.通过缓释疗法采用介入性青光眼治疗:眼科手术用药物的广泛影响。
Ophthalmol Ther. 2024 Nov;13(11):2825-2838. doi: 10.1007/s40123-024-01041-7. Epub 2024 Oct 10.
3
Experience of focused workshop intervention in presentation skills - Importance of foundational skills for ophthalmologists in training.
聚焦工作坊干预提升演讲技巧的经验——培训中眼科医生基础技能的重要性。
MedEdPublish (2016). 2024 May 29;14:18. doi: 10.12688/mep.20114.2. eCollection 2024.
4
Alternatives to Topical Glaucoma Medication for Glaucoma Management.用于青光眼治疗的局部用青光眼药物的替代方法。
Clin Ophthalmol. 2023 Dec 14;17:3899-3913. doi: 10.2147/OPTH.S439457. eCollection 2023.
5
Challenging the "Topical Medications-First" Approach to Glaucoma: A Treatment Paradigm in Evolution.挑战青光眼“局部用药优先”的治疗方法:一种不断演变的治疗模式。
Ophthalmol Ther. 2023 Dec;12(6):2823-2839. doi: 10.1007/s40123-023-00831-9. Epub 2023 Oct 19.
6
Assessment of the readability and quality of online patient education materials for the medical treatment of open-angle glaucoma.评估用于开角型青光眼治疗的在线患者教育材料的可读性和质量。
BMJ Open Ophthalmol. 2022 Mar 28;7(1):e000966. doi: 10.1136/bmjophth-2021-000966. eCollection 2022.
7
Extraction of Active Medications and Adherence Using Natural Language Processing for Glaucoma Patients.利用自然语言处理从青光眼患者中提取活性药物和用药依从性。
AMIA Annu Symp Proc. 2022 Feb 21;2021:773-782. eCollection 2021.
8
Patient Adherence to Glaucoma Treatment During the COVID-19 Pandemic.新冠疫情期间患者对青光眼治疗的依从性
Cureus. 2021 Jun 9;13(6):e15545. doi: 10.7759/cureus.15545. eCollection 2021 Jun.
9
Formulation Considerations for the Management of Dry Eye Disease.干眼症管理的制剂考量
Pharmaceutics. 2021 Feb 3;13(2):207. doi: 10.3390/pharmaceutics13020207.
10
Treatment choices for newly diagnosed primary open angle and ocular hypertension patients.初诊原发性开角型青光眼和高眼压症患者的治疗选择。
Eye (Lond). 2020 Jan;34(1):60-71. doi: 10.1038/s41433-019-0633-6. Epub 2019 Nov 4.